Jpmorgan Chase & CO Nuwellis, Inc. Transaction History

Jpmorgan Chase & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.56 - $2147.95 $115 - $442,477	206 Added 8.85%	2,534 $1,000
Q2 2022 Aug 11, 2022	SELL	$0.48 - $1.12 $54 - $127	-114 Reduced 4.67%	2,328 $1,000
Q1 2022 May 11, 2022	BUY	$0.85 - $1.27 $149 - $223	176 Added 7.77%	2,442 $2,000
Q4 2021 Feb 10, 2022	BUY	$1.13 - $2.26 $1,293 - $2,587	1,145 Added 102.14%	2,266 $3,000
Q3 2021 Nov 12, 2021	BUY	$2.12 - $4.6 $2,376 - $5,156	1,121 New	1,121 $2,000

Ticker NUWE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,531,600
Market Cap $55.8M
Description
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex ...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.